These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 12150646)
1. Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia. Albert KA; Hemmings HC; Adamo AI; Potkin SG; Akbarian S; Sandman CA; Cotman CW; Bunney WE; Greengard P Arch Gen Psychiatry; 2002 Aug; 59(8):705-12. PubMed ID: 12150646 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical and immunoblot analysis of Dopamine and cyclic AMP-regulated phosphoprotein, relative molecular mass 32,000 (DARPP-32) in the prefrontal cortex of subjects with schizophrenia and bipolar disorder. Ishikawa M; Mizukami K; Iwakiri M; Asada T Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1177-81. PubMed ID: 17521792 [TBL] [Abstract][Full Text] [Related]
3. N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia. Dracheva S; Marras SA; Elhakem SL; Kramer FR; Davis KL; Haroutunian V Am J Psychiatry; 2001 Sep; 158(9):1400-10. PubMed ID: 11532724 [TBL] [Abstract][Full Text] [Related]
4. Dopamine depletion alters phosphorylation of striatal proteins in a model of Parkinsonism. Brown AM; Deutch AY; Colbran RJ Eur J Neurosci; 2005 Jul; 22(1):247-56. PubMed ID: 16029214 [TBL] [Abstract][Full Text] [Related]
5. Involvement of a dysfunctional dopamine-D1/N-methyl-d-aspartate-NR1 and Ca2+/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine. Mouri A; Noda Y; Noda A; Nakamura T; Tokura T; Yura Y; Nitta A; Furukawa H; Nabeshima T Mol Pharmacol; 2007 Jun; 71(6):1598-609. PubMed ID: 17344353 [TBL] [Abstract][Full Text] [Related]
6. [DARPP-32 in the patients with endogenous psychosis]. Ishikawa M; Mizukami K Brain Nerve; 2007 Nov; 59(11):1257-63. PubMed ID: 18044203 [TBL] [Abstract][Full Text] [Related]
7. Medial prefrontal cortical synapsin II knock-down induces behavioral abnormalities in the rat: examining synapsin II in the pathophysiology of schizophrenia. Dyck BA; Beyaert MG; Ferro MA; Mishra RK Schizophr Res; 2011 Aug; 130(1-3):250-9. PubMed ID: 21689907 [TBL] [Abstract][Full Text] [Related]
9. Selective reduction of a PDZ protein, SAP-97, in the prefrontal cortex of patients with chronic schizophrenia. Toyooka K; Iritani S; Makifuchi T; Shirakawa O; Kitamura N; Maeda K; Nakamura R; Niizato K; Watanabe M; Kakita A; Takahashi H; Someya T; Nawa H J Neurochem; 2002 Nov; 83(4):797-806. PubMed ID: 12421351 [TBL] [Abstract][Full Text] [Related]
10. Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects. Pierri JN; Chaudry AS; Woo TU; Lewis DA Am J Psychiatry; 1999 Nov; 156(11):1709-19. PubMed ID: 10553733 [TBL] [Abstract][Full Text] [Related]
11. Altered DARPP-32 expression in the superior temporal gyrus in schizophrenia. Kunii Y; Yabe H; Wada A; Yang Q; Nishiura K; Niwa S Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1139-43. PubMed ID: 21453742 [TBL] [Abstract][Full Text] [Related]
12. Detailed DARPP-32 expression profiles in postmortem brains from patients with schizophrenia: an immunohistochemical study. Kunii Y; Ikemoto K; Wada A; Yang Q; Kusakabe T; Suzuki T; Niwa S Med Mol Morphol; 2011 Dec; 44(4):190-9. PubMed ID: 22179181 [TBL] [Abstract][Full Text] [Related]
13. Differential protein expression of DARPP-32 versus Calcineurin in the prefrontal cortex and nucleus accumbens in schizophrenia and bipolar disorder. Kunii Y; Hino M; Matsumoto J; Nagaoka A; Nawa H; Kakita A; Akatsu H; Hashizume Y; Yabe H Sci Rep; 2019 Oct; 9(1):14877. PubMed ID: 31619735 [TBL] [Abstract][Full Text] [Related]
14. Dopamine- and cAMP-regulated phosphoprotein DARPP-32: phosphorylation of Ser-137 by casein kinase I inhibits dephosphorylation of Thr-34 by calcineurin. Desdouits F; Siciliano JC; Greengard P; Girault JA Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2682-5. PubMed ID: 7708705 [TBL] [Abstract][Full Text] [Related]
15. The involvement of DARPP-32 in the pathophysiology of schizophrenia. Wang H; Farhan M; Xu J; Lazarovici P; Zheng W Oncotarget; 2017 Aug; 8(32):53791-53803. PubMed ID: 28881851 [TBL] [Abstract][Full Text] [Related]
16. Implications for altered glutamate and GABA metabolism in the dorsolateral prefrontal cortex of aged schizophrenic patients. Gluck MR; Thomas RG; Davis KL; Haroutunian V Am J Psychiatry; 2002 Jul; 159(7):1165-73. PubMed ID: 12091195 [TBL] [Abstract][Full Text] [Related]
17. Glutamate regulation of DARPP-32 phosphorylation in neostriatal neurons involves activation of multiple signaling cascades. Nishi A; Watanabe Y; Higashi H; Tanaka M; Nairn AC; Greengard P Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1199-204. PubMed ID: 15657149 [TBL] [Abstract][Full Text] [Related]
18. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Guidotti A; Auta J; Davis JM; Di-Giorgi-Gerevini V; Dwivedi Y; Grayson DR; Impagnatiello F; Pandey G; Pesold C; Sharma R; Uzunov D; Costa E Arch Gen Psychiatry; 2000 Nov; 57(11):1061-9. PubMed ID: 11074872 [TBL] [Abstract][Full Text] [Related]
19. Metabotropic mGlu5 receptors regulate adenosine A2A receptor signaling. Nishi A; Liu F; Matsuyama S; Hamada M; Higashi H; Nairn AC; Greengard P Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1322-7. PubMed ID: 12538871 [TBL] [Abstract][Full Text] [Related]
20. Synergistic interactions of dopamine D1 and glutamate NMDA receptors in rat hippocampus and prefrontal cortex: involvement of ERK1/2 signaling. Sarantis K; Matsokis N; Angelatou F Neuroscience; 2009 Nov; 163(4):1135-45. PubMed ID: 19647050 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]